We have also revealed that the VAV2-STAT1 axis can be targeted by STAT1 inhibitor to enhance radiosensitivity of cancer overexpressing VAV2, which might have an important implication in developing more effective and precision cancer radiotherapy. The gene discussed is STAT1; the disease is cancer.